Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Port Macquarie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
Noosa News10 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General14 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General12 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba
-
Noosa News19 hours agoWhat time does the NRL grand final kick off? When is the NRLW grand final?